Immunohistochemistry expression of targeted therapies biomarkers in ovarian clear cell and endometrioid carcinomas (type I) and endometriosis
article
OA: closed
CC0
⤵ 17 in-corpus citations
Limited metadata. Only one source feed has indexed
this record so far — no abstract, full text, or open-access copy is
available through Endo Lab. The
publisher's page (linked below)
is the canonical location for the actual content. If you have institutional
access, use "Find at my library".
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (38)
- Cancer Implications for Patients with Endometriosis via openalex
- Contents of Endometriotic Cysts, Especially the High Concentration of Free Iron, Are a Possible Cause of Carcinogenesis in the Cysts through the Iron-Induced Persistent Oxidative Stress via openalex
- <i>ARID1A</i> Mutations in Endometriosis-Associated Ovarian Carcinomas via openalex
- Loss of ARID1A Expression Is an Early Molecular Event in Tumor Progression From Ovarian Endometriotic Cyst to Clear Cell and Endometrioid Carcinoma via openalex
- Malignant Transformation of Pelvic Endometriosis via openalex
- Pathophysiology and Immune Dysfunction in Endometriosis via openalex
- Serum and peritoneal fluid levels of vascular endothelial growth factor in women with endometriosis. via openalex
- Serum and Peritoneal Fluid Levels of Vascular Endothelial Growth Factor in Women with Endometriosis via openalex
- W2099540110 via openalex
- W2102040834 via openalex
- W2111775556 via openalex
- W2134902059 via openalex
- W2135947389 via openalex
- W2155227851 via openalex
- W2213975839 via openalex
- W2239193252 via openalex
- W2277129094 via openalex
- W2299176878 via openalex
- W2300120435 via openalex
- W2300386653 via openalex
- W2404760029 via openalex
- W2514291160 via openalex
- W2523005380 via openalex
- W2584176612 via openalex
- W2704159227 via openalex
- W2747016053 via openalex
- W6646061739 via openalex
- W6697892651 via openalex
- W6700161591 via openalex
- W1975141727 via openalex
- W6742459247 via openalex
- W1982440526 via openalex
- W1985503139 via openalex
- W2001282311 via openalex
- W2036926790 via openalex
- W2042020498 via openalex
- W2077515764 via openalex
- W2091495172 via openalex
Cited by (17)
- Mechanistic insights into endocrine-disrupting chemicals in endometriosis and polycystic ovary syndrome: integrating network toxicology and molecular dynamics 2025
- Immunomodulation in Endometriosis: Investigating the interrelationship between VISTA expression and Escherichia.Shigella-Associated metabolites 2024
- Additional file 1 of PARP-1, EpCAM, and FRα as potential targets for intraoperative detection and delineation of endometriosis: a quantitative tissue expression analysis 2024
- Additional file 3 of PARP-1, EpCAM, and FRα as potential targets for intraoperative detection and delineation of endometriosis: a quantitative tissue expression analysis 2024
- Additional file 4 of PARP-1, EpCAM, and FRα as potential targets for intraoperative detection and delineation of endometriosis: a quantitative tissue expression analysis 2024
- Emerging bioengineering breakthroughs in precision diagnosis and therapy for endometriosis and adenomyosis 2024
- Additional file 3 of PARP-1, EpCAM, and FRα as potential targets for intraoperative detection and delineation of endometriosis: a quantitative tissue expression analysis 2024
- Additional file 2 of PARP-1, EpCAM, and FRα as potential targets for intraoperative detection and delineation of endometriosis: a quantitative tissue expression analysis 2024
- Additional file 1 of PARP-1, EpCAM, and FRα as potential targets for intraoperative detection and delineation of endometriosis: a quantitative tissue expression analysis 2024
- Additional file 2 of PARP-1, EpCAM, and FRα as potential targets for intraoperative detection and delineation of endometriosis: a quantitative tissue expression analysis 2024
- Additional file 4 of PARP-1, EpCAM, and FRα as potential targets for intraoperative detection and delineation of endometriosis: a quantitative tissue expression analysis 2024
- PARP-1, EpCAM, and FRα as potential targets for intraoperative detection and delineation of endometriosis: a quantitative tissue expression analysis 2023
- Plasma and Peritoneal Poly (ADP-Ribose) Polymerase Levels in Patients with Endometriosis 2022
- Endometriosis and endometriosis associated ovarian cancer 2021
- Endometriosis-Associated Ovarian Cancer: The Origin and Targeted Therapy 2020
- The value of the assesment of ARID1A expression, prostaglandin E2 synthase and the prostaglandin E2 receptor in patientswith genital endometriosis 2019
- Inhibition of KIF20A by BKS0349 reduces endometriotic lesions in a xenograft mouse model 2019
Source provenance
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-05-13T22:19:25.021412+00:00
License: CC0
· commercial use OK